Experimental studies on multijet production ine + e − annihilation at PETRA energies Jade Collaboration, W Bartel, L Becker, R Felst, D Haidt, G Knies, ... Zeitschrift für Physik C Particles and Fields 33, 23-31, 1986 | 1258 | 1986 |
Challenges in research and health technology assessment of rare disease technologies: report of the ISPOR rare disease special interest group S Nestler-Parr, D Korchagina, M Toumi, CL Pashos, C Blanchette, ... Value in Health 21 (5), 493-500, 2018 | 125 | 2018 |
Predicting life expectancy for pirfenidone in idiopathic pulmonary fibrosis M Fisher, SD Nathan, C Hill, J Marshall, F Dejonckheere, PO Thuresson, ... Journal of managed care & specialty pharmacy 23 (3-b Suppl), S17-S24, 2017 | 121 | 2017 |
Exploring the burden of X-linked hypophosphataemia: an opportunistic qualitative study of patient statements generated during a technology appraisal N Ferizović, J Marshall, AE Williams, MZ Mughal, N Shaw, C Mak, ... Advances in therapy 37, 770-784, 2020 | 29 | 2020 |
Impact of developmental and epileptic encephalopathies on caregivers: A literature review K Gallop, AJ Lloyd, J Olt, J Marshall Epilepsy & Behavior 124, 108324, 2021 | 28 | 2021 |
With a little help from some friends: Publishers, protesters, and Texas textbook decisions JD Marshall The politics of the textbook, 56-77, 2017 | 28 | 2017 |
Validation of a claims-based algorithm identifying eligible study subjects in the ADAPTABLE pragmatic clinical trial E Fishman, J Barron, J Dinh, WS Jones, A Marshall, R Merkh, ... Contemporary Clinical Trials Communications 12, 154-160, 2018 | 16 | 2018 |
Imaging of vanadium in microfossils: a new potential biosignature CP Marshall, A Olcott Marshall, JB Aitken, B Lai, S Vogt, P Breuer, ... Astrobiology 17 (11), 1069-1076, 2017 | 13 | 2017 |
Patient and caregiver health state utilities in Lennox-Gastaut syndrome and Dravet syndrome SH Lo, A Lloyd, J Marshall, K Vyas Clinical Therapeutics 43 (11), 1861-1876. e16, 2021 | 7 | 2021 |
The evolution of nice medtech innovation briefings and their associated technologies M Bullen, T Hughes, JD Marshall Value in Health 20 (9), A595, 2017 | 7 | 2017 |
Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome” K Hollenack, J Marshall PharmacoEconomics 39 (4), 473-475, 2021 | 5 | 2021 |
Trends in the use of cost-minimization analysis in Economic Assessments submitted to the SMC JD Marshall, M Harries, D Hill, CA Hill Value in Health 18 (3), A94, 2015 | 5 | 2015 |
Jade fever: Hunting the stone of heaven S Leaming, RD Hudson Heritage House Publishing Co, 2005 | 5 | 2005 |
Patient and caregiver health state utilities in tuberous sclerosis complex SH Lo, J Marshall, H Skrobanski, A Lloyd PharmacoEconomics-Open, 1-17, 2022 | 4 | 2022 |
PRO119 a novel mapping approach for estimating utilities in non-dystrophic myotonia A Lloyd, J Granerod, JD Marshall, C Domínguez-González, ... Value in Health 22, S863, 2019 | 3 | 2019 |
Exploring plan of care communication with a multidisciplinary rounding plan to nursing care plans AC Perera, S Joseph, JL Marshall, DWM Olson Journal of Neuroscience Nursing 55 (2), 49-53, 2023 | 2 | 2023 |
Epidemiology and disease burden of tuberous sclerosis complex in France: A population‐based study based on national health insurance data F Fagnani, C Laurendeau, M de Zelicourt, J Marshall Epilepsia open 7 (4), 633-644, 2022 | 2 | 2022 |
e Derogation of Women through Animal and Object Metaphors: Pejoration and Behavioral Traits S Jackson Ball State University, USA, 2016 | 2 | 2016 |
Why Doesn't an Igloo Melt Inside? A Handbook for Teachers of the Academically Gifted and Talented. J Patterson | 2 | 1973 |
Caregivers’ Perspectives on the Impact of Cannabidiol (CBD) Treatment for Dravet and Lennox-Gastaut Syndromes: A Multinational Qualitative Study J Marshall, H Skrobanski, L Moore-Ramdin, K Kornalska, P Swinburn, ... Journal of Child Neurology 38 (6-7), 394-406, 2023 | 1 | 2023 |